✦ LIBER ✦

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

✍ Scribed by Pardanani, A; Lasho, T; Finke, C; Oh, S T; Gotlib, J; Tefferi, A

Book ID: 109887205
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 350 KB
Volume: 24
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2010.163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IDH1 and IDH2 mutation analysis in chron

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms

✍ Tefferi, A; Pardanani, A; Lasho, T L; Finke, C M; Mai, M; McClure, R F 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 409 KB

Novel mutations and their functional and

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

✍ Tefferi, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 548 KB

Myeloproliferative neoplasms (MPNs) originate from genetically transformed hematopoietic stem cells that retain the capacity for multilineage differentiation and effective myelopoiesis. Beginning in early 2005, a number of novel mutations involving Janus kinase 2 (__JAK2)__, Myeloproliferative Leuke

IDH1 and IDH2 mutation studies in 1473 p

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

✍ Tefferi, A; Lasho, T L; Abdel-Wahab, O; Guglielmelli, P; Patel, J; Caramazza, D; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 460 KB

Concomitant analysis of EZH2 and ASXL1 m

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

✍ Abdel-Wahab, O; Pardanani, A; Patel, J; Wadleigh, M; Lasho, T; Heguy, A; Beran, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 220 KB